M11.08 Hydroxyapatite deposition disease, vertebrae

Name of the Condition

• Hydroxyapatite deposition disease, vertebrae

Summary

Hydroxyapatite deposition disease (HADD) of the vertebrae is a condition characterized by the deposition of calcium phosphate crystals (hydroxyapatite) in soft tissues of the spinal region, often leading to inflammation and pain. It typically affects periarticular structures around the vertebrae and can cause localized discomfort or functional impairment. Diagnosis relies on clinical evaluation, imaging, and exclusion of other spinal conditions.

Causes

HADD is caused by the deposition of hydroxyapatite crystals in soft tissues of the vertebrae, such as ligaments or tendons. The exact trigger for crystal formation is not fully understood but may involve tissue injury, metabolic imbalances, or chronic inflammation. The crystals can provoke an inflammatory response, contributing to symptoms.

Risk Factors

• Repetitive spinal motion or overuse.
• Trauma to the spinal region.
• Metabolic disorders (e.g., diabetes, hyperparathyroidism).
• Advanced age.
• Chronic kidney disease.

Symptoms

• Localized pain and tenderness in the spinal area.
• Stiffness, especially after inactivity.
• Reduced range of motion.
• Possible acute inflammatory episodes.
• Pain that may worsen with movement or pressure.

Diagnosis

Diagnosis involves clinical assessment of symptoms, imaging (e.g., X-rays, MRI) to detect crystal deposits, and exclusion of other spinal conditions. Imaging may show calcific deposits, though crystal identification is not always required for diagnosis.

Treatment Options

• Rest and activity modification to reduce strain.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation.
• Physical therapy to improve mobility and strength.
• Corticosteroid injections for severe or persistent symptoms.
• Management of underlying metabolic conditions, if present.

Prognosis and Follow-Up

Prognosis is generally favorable, as HADD often resolves spontaneously or with conservative treatment. Follow-up may involve monitoring symptoms and functional improvement. Recurrence is possible, especially with repeated trauma or unmanaged risk factors.

Complications

• Chronic pain or stiffness if untreated.
• Reduced mobility or functional impairment.
• Potential for misdiagnosis as other spinal conditions (e.g., degenerative disc disease).

Lifestyle & Prevention

• Maintain proper posture and ergonomic practices.
• Avoid repetitive or excessive spinal strain.
• Manage metabolic conditions to reduce risk.
• Engage in regular, low-impact exercise to support spinal health.

When to Seek Professional Help

Seek care if symptoms persist beyond a few days, worsen, or interfere with daily activities. Immediate attention is needed for severe pain, neurological symptoms (e.g., numbness, weakness), or signs of infection.

Tips for Medical Coders

Document the specific spinal region affected (e.g., cervical, thoracic, lumbar) and any associated symptoms or complications. Ensure clinical correlation with imaging findings to support the diagnosis. Note any underlying metabolic conditions or trauma that may contribute to the condition.